We are live on ! Find out more
BNTX icon

BioNTech

283 hedge funds and large institutions have $7.83B invested in BioNTech in 2021 Q2 according to their latest regulatory filings, with 95 funds opening new positions, 72 increasing their positions, 80 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more funds holding in top 10

Funds holding in top 10: 16 (+5)

157% more first-time investments, than exits

New positions opened: 95 | Existing positions closed: 37

141% more capital invested

Capital invested by funds: $3.25B → $7.83B (+$4.58B)

26% more funds holding

Funds holding: 225283 (+58)

2.12% more ownership

Funds ownership: 12.53%14.65% (+2.1%)

10% less repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 80

33% less call options, than puts

Call options by funds: $728M | Put options by funds: $1.08B

Holders
283
Holders Change
+58
Holders Change %
+25.78%
% of All Funds
4.93%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.1%
New
95
Increased
72
Reduced
80
Closed
37
Calls
$728M
Puts
$1.08B
Net Calls
-$352M
Net Calls Change
-$261M
Name Holding Trade Value Shares
Change
Change in
Stake
Zurich Cantonal Bank
101
Zurich Cantonal Bank
Switzerland
$3.18M -$1.88M -9,963 -41%
BMSSC
102
B. Metzler seel. Sohn & Co
Germany
$2.96M +$2.53M +13,410 New
PAG
103
Private Advisor Group
New Jersey
$2.9M +$377 +2 +0%
Macquarie Group
104
Macquarie Group
Australia
$2.87M +$2.42M +12,806 New
BCV
105
Banque Cantonale Vaudoise
Switzerland
$2.47M +$1.89M +10,000 +952%
BCM
106
Bronte Capital Management
Australia
$2.45M +$2.07M +10,963 New
Simplex Trading
107
Simplex Trading
Illinois
$2.44M +$2.05M +10,890 New
PC
108
PointState Capital
New York
$2.24M -$3.34M -17,700 -64%
CSS
109
Cubist Systematic Strategies
Connecticut
$2.22M +$1.87M +9,922 New
BPC
110
Banque Pictet & Cie
Switzerland
$2.15M +$417K +2,210 +30%
VIA
111
Vident Investment Advisory
Georgia
$2.04M -$2.43M -12,880 -59%
EIM
112
Essex Investment Management
Massachusetts
$2.03M
D.E. Shaw & Co
113
D.E. Shaw & Co
New York
$2M -$96.7K -513 -5%
State Street
114
State Street
Massachusetts
$1.97M +$194K +1,031 +13%
Squarepoint
115
Squarepoint
New York
$1.97M +$1.66M +8,779 New
LSA
116
Leonteq Securities AG
Switzerland
$1.91M -$365K -1,936 -18%
BC
117
BIT Capital
Germany
$1.85M
PWM
118
Purus Wealth Management
California
$1.8M -$54.1K -287 -3%
Commonwealth Equity Services
119
Commonwealth Equity Services
Massachusetts
$1.8M -$99.6K -528 -6%
AIM
120
Aigen Investment Management
New York
$1.77M +$1.49M +7,913 New
NFC
121
Northeast Financial Consultants
Connecticut
$1.77M
LC
122
Longitude (Cayman)
Cayman Islands
$1.57M +$1.32M +7,000 New
Baird Financial Group
123
Baird Financial Group
Wisconsin
$1.47M +$1.24M +6,558 New
CCB
124
Cutter & Co Brokerage
Missouri
$1.45M
Invesco
125
Invesco
Georgia
$1.39M +$1.17M +6,195 New

BNTX Hedge Fund Activity: Q2 2021 in Review

283 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q2 2021, worth a combined $7.83B — up 141% from $3.25B a quarter earlier.

Buyers outnumbered sellers: 95 funds opened new BNTX positions and 37 closed out — a net gain of 58 holders — while 72 added to existing stakes and 80 trimmed.

The largest buyer was Capital World Investors, adding an estimated $561M. The largest seller was Artisan Partners, cutting an estimated $150M.

  • 283 institutional investors held BioNTech (BNTX) as of Q2 2021, up from 225 in Q1 2021.
  • Funds reported $7.83B of BioNTech stock for Q2 2021, up 141% quarter-over-quarter.
  • 95 funds opened new BioNTech positions in Q2 2021 and 37 closed out, a net change of +58 holders.
  • The largest BioNTech buyer in Q2 2021 was Capital World Investors, an estimated $561M added.
  • The largest BioNTech seller in Q2 2021 was Artisan Partners, an estimated $150M sold.

Based on aggregated 13F filings for Q2 2021.